Oncotarget:外泌体miRNA竟然与乳腺癌复发有关!

2017-08-16 Emma MedSci原创

外泌体(Exosome)是指经由细胞内的囊泡运输,从多泡体排出到细胞外的直径为30-100nm左右的细胞外囊泡。

外泌体(Exosome)是指经由细胞内的囊泡运输,从多泡体排出到细胞外的直径为30-100nm左右的细胞外囊泡。外泌体内部含有蛋白质、脂质、核酸等,被分泌到细胞外后,经由体液被相邻或远离的组织吸收,发挥着细胞间信息传递载体的作用。外泌体miRNA(Exosomal microRNAs)的分析与细胞、组织特异性以及与疾病间的联系引起了研究人员的关注。

研究人员调查了外泌体miRNA在乳腺癌患者血清样品中的预后作用,并比较了血清和肿瘤组织之间的miRNA表达。研究人员通过miRNA PCR芯片分析乳腺癌复发患者(n = 16)与乳腺癌无复发患者(n = 16)的外泌体miRNA谱,并通过qRT-PCR检查乳腺癌复发患者(n = 35)组织和乳腺癌无复发患者(n = 39)组织的miRNA表达情况。

结果显示,在384个miRNA中,乳腺癌复发患者中有3个miRNA(miR-338-3p,miR-340-5p和miR-124-3p)显著上调,8个miRNA(miR-29b-3p,miR-20b-5p,miR-17-5p,miR-130a-3p,miR-18a-5p,miR-195-5p,miR-486-5p和miR-93-5p )显著下调。分析miRNA在肿瘤组织中的表达显示,乳腺癌复发患者在其原发部位和血清中具有较高水平的miR-340,而其肿瘤组织的miR-195-5p, miR-17-5p, miR-93-5p, and miR-130a-3p在其血清中下调,但是这些miRNA在乳腺癌复发患者肿瘤中表达高于乳腺癌无复发患者。Logistic回归分析显示,miR-340-5p,miR-17-5p,miR-130a-3p和miR-93-5p与乳腺癌患者复发显著相关。

该研究表明,miR-340-5p,miR-17-5p,miR-130a-3p和miR-93-5p这几种外泌体miRNA可能是预测乳腺癌复发的有用生物标志物,而miRNA在肿瘤组织和血清之间能够显示出不同的表达模式。这些发现表明,癌细胞可能通过释放外泌体miRNA的选择性机制来调节其自身的进程,这为对于癌细胞的进一步的研究提供参考。

原始出处:
Sueta A, et al. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence. Oncotarget. 2017 Jul 22. doi: 10.18632/oncotarget.19482.

本文系梅斯医学(MedSci)原创翻译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1795435, encodeId=561c1e954356e, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Sep 29 15:21:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312309, encodeId=78bf131230910, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Aug 18 05:21:00 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930500, encodeId=a1a11930500ab, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Dec 19 19:21:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234139, encodeId=ffaa234139a9, content=外泌体(Exosome)是指经由细胞内的囊泡运输,从多泡体排出到细胞外的直径为30-100nm左右的细胞外囊泡。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Wed Aug 16 18:24:47 CST 2017, time=2017-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234126, encodeId=1fb42341263e, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Wed Aug 16 15:40:50 CST 2017, time=2017-08-16, status=1, ipAttribution=)]
    2017-09-29 仁医06
  2. [GetPortalCommentsPageByObjectIdResponse(id=1795435, encodeId=561c1e954356e, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Sep 29 15:21:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312309, encodeId=78bf131230910, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Aug 18 05:21:00 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930500, encodeId=a1a11930500ab, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Dec 19 19:21:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234139, encodeId=ffaa234139a9, content=外泌体(Exosome)是指经由细胞内的囊泡运输,从多泡体排出到细胞外的直径为30-100nm左右的细胞外囊泡。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Wed Aug 16 18:24:47 CST 2017, time=2017-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234126, encodeId=1fb42341263e, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Wed Aug 16 15:40:50 CST 2017, time=2017-08-16, status=1, ipAttribution=)]
    2017-08-18 Homburg
  3. [GetPortalCommentsPageByObjectIdResponse(id=1795435, encodeId=561c1e954356e, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Sep 29 15:21:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312309, encodeId=78bf131230910, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Aug 18 05:21:00 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930500, encodeId=a1a11930500ab, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Dec 19 19:21:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234139, encodeId=ffaa234139a9, content=外泌体(Exosome)是指经由细胞内的囊泡运输,从多泡体排出到细胞外的直径为30-100nm左右的细胞外囊泡。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Wed Aug 16 18:24:47 CST 2017, time=2017-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234126, encodeId=1fb42341263e, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Wed Aug 16 15:40:50 CST 2017, time=2017-08-16, status=1, ipAttribution=)]
    2017-12-19 smallant2002
  4. [GetPortalCommentsPageByObjectIdResponse(id=1795435, encodeId=561c1e954356e, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Sep 29 15:21:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312309, encodeId=78bf131230910, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Aug 18 05:21:00 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930500, encodeId=a1a11930500ab, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Dec 19 19:21:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234139, encodeId=ffaa234139a9, content=外泌体(Exosome)是指经由细胞内的囊泡运输,从多泡体排出到细胞外的直径为30-100nm左右的细胞外囊泡。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Wed Aug 16 18:24:47 CST 2017, time=2017-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234126, encodeId=1fb42341263e, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Wed Aug 16 15:40:50 CST 2017, time=2017-08-16, status=1, ipAttribution=)]
    2017-08-16 随梦飞扬

    外泌体(Exosome)是指经由细胞内的囊泡运输,从多泡体排出到细胞外的直径为30-100nm左右的细胞外囊泡。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1795435, encodeId=561c1e954356e, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Sep 29 15:21:00 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1312309, encodeId=78bf131230910, content=<a href='/topic/show?id=e5571193321' target=_blank style='color:#2F92EE;'>#miRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11933, encryptionId=e5571193321, topicName=miRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e87d405, createdName=Homburg, createdTime=Fri Aug 18 05:21:00 CST 2017, time=2017-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930500, encodeId=a1a11930500ab, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Dec 19 19:21:00 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234139, encodeId=ffaa234139a9, content=外泌体(Exosome)是指经由细胞内的囊泡运输,从多泡体排出到细胞外的直径为30-100nm左右的细胞外囊泡。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/02/7354b3539aae6a0ccb1e0fff04c12084.jpg, createdBy=205b1984786, createdName=随梦飞扬, createdTime=Wed Aug 16 18:24:47 CST 2017, time=2017-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=234126, encodeId=1fb42341263e, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/25/aee510ed68ce4736e9fe4ec7d03c01b1.jpg, createdBy=ce892064652, createdName=楠博One, createdTime=Wed Aug 16 15:40:50 CST 2017, time=2017-08-16, status=1, ipAttribution=)]
    2017-08-16 楠博One

    学习谢谢分享

    0

相关资讯

Int J Nanomed:新型纳米载药系统可更好的抑制乳腺癌细胞

抗癌金属复合体的纳米给药系统的合理设计和构建是提高肿瘤细胞中药物的溶解度、渗透性以及停留率的重要策略。本研究中,研究人员设计并合成了转铁蛋白(Tf)-共轭纳米烯氧化物(NGO)的纳米系统作为肿瘤靶向药物铂复合物的纳米载体(Tf-NGO@Pt)。经评估显示这种纳米药物载体系统在生理条件下具有良好的溶解性。此外,与铂复合物相比,Tf-NGO@Pt对MCF人乳腺癌细胞表现出较好的抗癌疗效,并能有效地抑制

NEJM:Olaparib为有BRCA突变的转移性乳腺癌患者带来希望

Olaparib是一种口服多聚二磷酸腺苷核糖聚合酶抑制剂,在转移性乳腺癌和有BRCA突变的患者中表现出很好的抗肿瘤活性。

重复:JCO:一箭双雕 双膦酸盐治疗绝经后女性骨质疏松还能降低乳腺癌风险?

当前,有关绝经后女性使用双膦酸盐与乳腺癌风险相关性的研究结论各不相同。2017年7月,发表在《J Clin Oncol.》的一项2004年至2011年的绝经后女性观察性队列研究表明,双膦酸盐用于治疗绝经后女性骨质疏松不会降低乳腺癌发生率。

NEJM:BRCA生殖系突变阳性的晚期乳腺癌:奥拉帕尼(Olaparib)有力回天?

奥拉帕尼(Olaparib)是一种口服PARP(poly ADP-ribose polymerase)抑制剂。既往已有多项I、II期临床试验证实了PARP抑制剂在转移性乳腺癌、BRCA生殖系突变肿瘤中的疗效。但目前尚无III期随机对照研究的数据支持奥拉帕尼在转移性乳腺癌患者中的临床应用。近期,Pierfranco Conte教授等研究者牵头,一项汇聚了美、英、中、日、韩等多中心合作的、随机、开放的

Ann Oncol:β阻滞剂或可使三阴性乳腺癌患者的PFS增加2倍以上?

对Ⅲ期随机ROSE/TRIO-012数据回顾性分析,发现使用β阻滞剂显着改善患者的PFS,且与试验药物雷莫卢单抗及治疗相关高血压无关。因研究选择终点为PFS,小编认为PFS延长与β阻滞剂心脏保护作用联系不大。本研究价值在于,若抗肿瘤治疗出现高血压,可优先考虑β阻滞剂。

ANN ONCOL:早期乳腺癌治疗——2017 St. Gallen国际专家共识

2017年3月,第15届St. Gallen国际乳腺癌会议在奥地利维也纳顺利召开。今年St. Gallen会议的主题是乳腺癌治疗的“加减法”(escalation and de-escalation),相关专家共识也已陆续发布。本文即是对早期乳腺癌共识部分的介绍。 今年St. Gallen会议的主题是乳腺癌治疗的“加减法”(escalation and de-escalation),相关专家